Search
ethinyl estradiol/segesterone acetate (Annovera)
Indications:
- reusable vaginal ring contraceptive
Procedure:
- placed in the vagina for 3 weeks
- removed for 1 week during which time a woman may menstruate
- during the off week, the ring is washed & stored in a case
Adverse effects:
- boxed warning: risk for serious cardiovascular events in smokers
Complications:
- 2-4% of women using Annovera may get pregnant in the 1st year
General
hormonal contraceptive
vaginal ring
pharmacologic combination
References
- FDA News Release. Aug 10, 2018
FDA approves new vaginal ring for one year of birth control.
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm616541.htm
Components
ethinyl estradiol
segesterone acetate